MeSH D012883 - skin ulcer
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Johnson & Johnson | Becaplermin | Regranex | 1999-03-29 | |||
| Auxilium Pharmaceuticals | Collagenase clostridium histolyticum | Xiaflex | 2010-02-02 | |||
| Orphan Medical | Collagenase clostridium histolyticum | Xiapex | 2011-02-28 | |||
| Smith+Nephew | Collagenase clostridium histolyticum | Santyl | 1965-06-04 | |||
| Endo | Collagenase clostridium histolyticum | Qwo | 2020-07-06 |
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
0%0/2
Phase 3
100%7/7
Approved: 6Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use